TrialFrontiers in endocrinology2026

Comparative effectiveness of pemafibrate versus bezafibrate on hepatic and vascular endothelial function in patients with coronary artery disease and metabolic dysfunction-associated steatotic liver disease.

Akihiro Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.